Indications And Dose
Pain and inflammation in rheumatic disease and other musculoskeletal disorders | Mild to moderate pain including dysmenorrhoea | Postoperative analgesia | Dental pain ▶BY MOUTH USING IMMEDIATE-RELEASE MEDICINES ▶Adult: Initially 300–400 mg 3–4 times a day; increased if necessary up to 600 mg 4 times a day; maintenance 200–400 mg 3 times a day, may be adequate ▶BY MOUTH USING MODIFIED-RELEASE MEDICINES ▶Adult: 1.6 g once daily, dose to be taken in the early evening, increased if necessary to 2.4 g daily in 2 divided doses, dose to be increased only in severe cases Acute migraine ▶BY MOUTH USING IMMEDIATE-RELEASE MEDICINES ▶Adult: 400–600 mg for 1 dose, to be taken as soon as migraine symptoms develop Mild to moderate pain | Pain and inflammation of soft- tissue injuries | Pyrexia with discomfort ▶BY MOUTH USING IMMEDIATE-RELEASE MEDICINES ▶Child 3–5 months: 50 mg 3 times a day, maximum daily dose to be given in 3–4 divided doses; maximum continued → 30 mg/kg per day ▶Child 6–11 months: 50 mg 3–4 times a day, maximum daily dose to be given in 3–4 divided doses; maximum 30 mg/kg per day ▶Child 1–3 years: 100 mg 3 times a day, maximum daily dose to be given in 3–4 divided doses; maximum 30 mg/kg per day ▶Child 4–6 years: 150 mg 3 times a day, maximum daily dose to be given in 3–4 divided doses; maximum 30 mg/kg per day ▶Child 7–9 years: 200 mg 3 times a day, maximum daily dose to be given in 3–4 divided doses; maximum 30 mg/kg per day; maximum 2.4 g per day ▶Child 10–11 years: 300 mg 3 times a day, maximum daily dose to be given in 3–4 divided doses; maximum 30 mg/kg per day; maximum 2.4 g per day ▶Child 12–17 years: Initially 300–400 mg 3–4 times a day; Musculoskeletal system increased if necessary up to 600 mg 4 times a day; maintenance 200–400 mg 3 times a day, may be adequate Pain and inflammation ▶BY MOUTH USING MODIFIED-RELEASE MEDICINES ▶Child 12–17 years: 1.6 g once daily, dose preferably taken in the early evening, increased to 2.4 g daily in 2 divided doses, dose to be increased only in severe cases Pain and inflammation in rheumatic disease including juvenile idiopathic arthritis ▶BY MOUTH USING IMMEDIATE-RELEASE MEDICINES ▶Child 3 months–17 years: 30–40 mg/kg daily in 3–4 divided doses; maximum 2.4 g per day Pain and inflammation in systemic juvenile idiopathic arthritis ▶BY MOUTH USING IMMEDIATE-RELEASE MEDICINES ▶Child 3 months–17 years: Up to 60 mg/kg daily in 4–6 divided doses; maximum 2.4 g per day Post-immunisation pyrexia in infants (on doctor’s advice only) ▶BY MOUTH USING IMMEDIATE-RELEASE MEDICINES ▶Child 2–3 months: 50 mg for 1 dose, followed by 50 mg after 6 hours if required Pain relief in musculoskeletal conditions | Treatment in knee or hand osteoarthritis (adjunct) ▶TO THE SKIN ▶Adult: Apply up to 3 times a day, ibuprofen gel 5% gel to be administered Pain and inflammation in rheumatic disease and other musculoskeletal disorders (dose approved for use by community practitioner nurse prescribers) | Mild to moderate pain including dysmenorrhoea (dose approved for use by community practitioner nurse prescribers) | Migraine (dose approved for use by community practitioner nurse prescribers) | Dental pain (dose approved for use by community practitioner nurse prescribers) | Headache (dose approved for use by community practitioner nurse prescribers) | Fever (dose approved for use by community practitioner nurse prescribers) | Symptoms of colds and influenza (dose approved for use by community practitioner nurse prescribers) | Neuralgia (dose approved for use by community practitioner nurse prescribers) ▶BY MOUTH USING IMMEDIATE-RELEASE MEDICINES ▶Child 12–17 years: 200–400 mg 3 times a day, if symptoms worsen or persist for more than 3 days refer to doctor ▶Adult: 200–400 mg 3 times a day, if symptoms worsen or persist for more than 10 days refer to doctor Mild to moderate pain (dose approved for use by community practitioner nurse prescribers) | Pain and inflammation of soft-tissue injuries (dose approved for use by community practitioner nurse prescribers) | Pyrexia with discomfort (dose approved for use by community practitioner nurse prescribers) ▶BY MOUTH USING IMMEDIATE-RELEASE MEDICINES ▶Child 3–5 months (body-weight 5 kg and above): 20–30 mg/kg daily in divided doses, alternatively 50 mg 3 times a day for maximum of 24 hours, refer to doctor if symptoms persist for more than 24 hours ▶Child 6–11 months: 50 mg 3–4 times a day, refer to doctor if symptoms persist for more than 3 days ▶Child 1–3 years: 100 mg 3 times a day, refer to doctor if symptoms persist for more than 3 days ▶Child 4–6 years: 150 mg 3 times a day, refer to doctor if symptoms persist for more than 3 days ▶Child 7–9 years: 200 mg 3 times a day, refer to doctor if symptoms persist for more than 3 days ▶Child 10–11 years: 300 mg 3 times a day, refer to doctor if symptoms persist for more than 3 days Post-immunisation pyrexia in infants (dose approved for use by community practitioner nurse prescribers) (on doctor’s advice only) ▶BY MOUTH USING IMMEDIATE-RELEASE MEDICINES ▶Child 3 months: 50 mg for 1 dose, followed by 50 mg after 6 hours if required, if pyrexia persists refer to doctor FENBID ® FORTE Pain relief in musculoskeletal conditions | Treatment in knee or hand osteoarthritis (adjunct) ▶TO THE SKIN ▶Adult: Apply up to 4 times a day, therapy should be reviewed after 14 days IBUGEL ® FORTE Pain relief in musculoskeletal conditions | Treatment in knee or hand osteoarthritis (adjunct) ▶TO THE SKIN ▶Adult: Apply up to 3 times a day l UNLICENSED USE ▶With oral use in children Not licensed for use in children under 3 months or body-weight under 5 kg. Maximum dose for systemic juvenile idiopathic arthritis is unlicensed.
Source pages 1225, 1226